AR016036A1 - Derivados de tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica y el uso de los mismos para la fabricacion de unmedicamento - Google Patents

Derivados de tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica y el uso de los mismos para la fabricacion de unmedicamento

Info

Publication number
AR016036A1
AR016036A1 ARP990102365A ARP990102365A AR016036A1 AR 016036 A1 AR016036 A1 AR 016036A1 AR P990102365 A ARP990102365 A AR P990102365A AR P990102365 A ARP990102365 A AR P990102365A AR 016036 A1 AR016036 A1 AR 016036A1
Authority
AR
Argentina
Prior art keywords
alkyl
optionally substituted
group
alkoxy
ring
Prior art date
Application number
ARP990102365A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR016036A1 publication Critical patent/AR016036A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Derivados de tetrahidroisoquinolina de formula (I): en la cual R1 representa un sustituyente seleccionado de: un átomo de hidrogeno o halogeno; un grupohidroxi, ciano, nitro, trifluorometilo, trifluorometoxi, trifluorometanosulfoniloxi, pentafluoretilo, alquilo C1-4, aril-alcoxi C1-4, alquitio C1-4, alcoxiC1-4-alquilo C1-4, cicloalquil C3-6-alcoxi C1-4, alcanoílo C1-4, alcoxi C1-4-carbonilo, alquilsulfonilo C1-4, alquilsulfoniloxi C1-4, alquilsulfonil C1-4-alquilo C1-4, arilsulfonilo, arilsulfoniloxi, arilsulfonilalquilo C1-4, alquilsulfonamido C1-4, alquil C1-4-amido, alquilsulfonamido C1-4-alquilo C1-4, alquilC1-4-amido-alquilo C1-4, aril-sulfonamido, arilcarboxamido, arilsulfonamido-alquilo C1-4, arilcarboxamido-alquilo C1-4, aroílo, aroilalquilo C1-4, oaril-alcanoílo C1-4; un grupo R3OCO(CH2)p, R3CON(R4)(CH2)p, R3R4NCO(CH2)p o R3R4NSO2(CH2)p donde cada uno de R3 y R4 representa independientemente un átomo dehidrogeno o un grupo alquilo C1-4, o R3R4 forma parte de un anillo de azacicloalcano C3-6 o (2-oxo)azacicloalcano C3-6 y p representa cero o un numero enterode 1 a 4; o un grupo Ar1-Z, en el cual Ar1 representa un anillo de fenilo opcionalmente sustituido o un anillo aromático heterocíclico de 5 o 6 miembrosopcionalmente sustituido y Z representa un enlace, O, S, o CH2; R2 representa un átomo de hidrogeno o un grupo alquilo C1-4; q es 1 o 2; A representa un grupode la formula: -(CH2)r-V-(CH2)s-Ar en la cual r y s representan independientemente un numero entero de 0 a 3tal que la suma de r y s es igual a un numeroentero de 1 a 4; V representa un enlace, O o S; Ar representa un anillo de fenilo opcionalmente sustituido o un anillo aromático heterocíclico de 5 o 6miembros opcionalmente sustituido; o un sistema de anillos bicíclico opcionalmente sustituido; y sus sales. Los compuestos son utiles para el tratamiento decondiciones que requieren modulacion de un receptor de dopamina, tales como esquizofrenia. Además, se describe un procedimiento para su preparacion, unacomposicion farmacéutica y el uso de los mismos para la fabricacion de un medicamento.
ARP990102365A 1998-05-20 1999-05-18 Derivados de tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica y el uso de los mismos para la fabricacion de unmedicamento AR016036A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9810876.4A GB9810876D0 (en) 1998-05-20 1998-05-20 Compounds

Publications (1)

Publication Number Publication Date
AR016036A1 true AR016036A1 (es) 2001-05-30

Family

ID=10832418

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102365A AR016036A1 (es) 1998-05-20 1999-05-18 Derivados de tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica y el uso de los mismos para la fabricacion de unmedicamento

Country Status (9)

Country Link
US (1) US6414154B1 (es)
EP (1) EP1086084A1 (es)
JP (1) JP2002515489A (es)
AR (1) AR016036A1 (es)
AU (1) AU4262799A (es)
CA (1) CA2332316A1 (es)
CO (1) CO5031252A1 (es)
GB (1) GB9810876D0 (es)
WO (1) WO1999059974A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69929704T2 (de) 1998-10-08 2006-07-20 Smithkline Beecham Plc, Brentford Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel)
HU227543B1 (en) * 2001-09-28 2011-08-29 Richter Gedeon Nyrt N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them
US7589207B2 (en) 2002-12-13 2009-09-15 Smithkline Beecham Corporation Cyclohexyl compounds as CCR5 antagonists
US10870660B2 (en) 2016-07-28 2020-12-22 Shionogi & Co., Ltd. Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect
JPWO2019146739A1 (ja) * 2018-01-26 2021-01-07 塩野義製薬株式会社 ドーパミンｄ３受容体拮抗作用を有する縮環化合物

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA792785B (en) 1978-07-07 1980-08-27 Smithkline Corp Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
US4220778A (en) 1978-10-30 1980-09-02 G. D. Searle & Co. 8-Aryl-1,2,3,4-tetrahydroisoquinoline and derivatives thereof
IL63918A0 (en) 1980-10-17 1981-12-31 Pennwalt Corp N-(amino(or hydroxy)phenethyl)-1,2,3,4-tetrahydroisoquinolines,their preparation and pharmaceutical compositions containing them
ZA816903B (en) 1980-10-17 1983-02-23 Pennwalt Corp N-(amino(or hydroxy)-1,2,3,4,-tetrahydroisoquinolines, precursors thereof, and methods of preparation
FR2618149B1 (fr) 1987-07-16 1989-09-22 Synthelabo Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique
IL89156A (en) 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
US5217977A (en) 1989-02-28 1993-06-08 Imperial Chemical Industries Plc Heterocyclic cycloalkanes
US5047406A (en) 1989-12-06 1991-09-10 Warner-Lambert Co. Substituted cyclohexanols as central nervous system agents
JP2800953B2 (ja) 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
US5633376A (en) 1990-12-28 1997-05-27 Neurogen Corporation Certain aminomethyl phenylimidazole derivatives; and 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype ligands
WO1992012132A1 (en) 1991-01-11 1992-07-23 Laboratoires Glaxo S.A. Acridine derivatives
WO1993003025A1 (fr) 1991-08-09 1993-02-18 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thiophene
EP0596125A4 (en) 1991-12-26 1994-10-05 Yoshitomi Pharmaceutical Condensed thiophene compound and pharmaceutical use thereof.
US5532240A (en) 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
GB9206757D0 (en) 1992-03-27 1992-05-13 Ferring Bv Novel peptide receptor ligands
EP0649410B1 (en) 1992-07-10 1997-05-02 Laboratoires Glaxo Sa Anilide derivatives
KR950702962A (ko) 1992-08-06 1995-08-23 데이비드 로버츠 도파민 D₃수용체 길항제인 5-(2-옥시페닐)-피롤 유도체(5-(2-Oxyphenyl)-Pyrrole Derivatives as Dopamine D₃Receptor Antagonists)
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
GB9305644D0 (en) 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
GB9307400D0 (en) 1993-04-08 1993-06-02 Smithkline Beecham Plc Compounds
JP2959615B2 (ja) 1993-06-24 1999-10-06 吉富製薬株式会社 縮合型チオフェン化合物およびその医薬用途
WO1995000508A1 (en) 1993-06-25 1995-01-05 Smithkline Beecham Plc Phenyrrole derivatives and their use as dopamine d3 antagonists
GB9315801D0 (en) 1993-07-30 1993-09-15 Smithkline Beecham Plc Compounds
HUT75876A (en) 1993-08-12 1997-05-28 Astra Ab Amidine derivatives with nitric oxide synthetase activities, pharmaceutical compositions containing them and process for their preparation
GB9320855D0 (en) 1993-10-09 1993-12-01 Smithkline Beecham Plc Compounds
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
GB9325827D0 (en) 1993-12-17 1994-02-23 Smithkline Beecham Plc Compounds
GB9402197D0 (en) 1994-02-04 1994-03-30 Smithkline Beecham Plc Compounds
GB9402807D0 (en) 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9403199D0 (en) 1994-02-19 1994-04-13 Smithkline Beecham Plc Compounds
CA2187429A1 (en) 1994-04-28 1995-11-09 Junya Ohmori N-(3-pyrrolidinyl)benzamide derivative
US5414010A (en) 1994-05-10 1995-05-09 Warner-Lambert Company Dimeric benzimidazoles as central nervous system agents
DE4425143A1 (de) 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
GB9418912D0 (en) 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
WO1996011007A1 (en) 1994-10-05 1996-04-18 Glaxo Wellcome Inc. Parenteral pharmaceutical compositions containing gf120918a
US5478934A (en) 1994-11-23 1995-12-26 Yuan; Jun Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands
GB9426071D0 (en) 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB9426090D0 (en) 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
GB9426224D0 (en) 1994-12-23 1995-02-22 Xenova Ltd Pharmaceutical compounds
US5891877A (en) 1995-02-14 1999-04-06 Xenova Limited Pharmaceutical compounds
EP0809641A1 (en) 1995-02-15 1997-12-03 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
GB9512129D0 (en) 1995-06-15 1995-08-16 Smithkline Beecham Plc Compounds
AU6859096A (en) 1995-09-22 1997-04-09 Warner-Lambert Company Substituted cyclohexylamines as central nervous system agents
FR2741074B1 (fr) 1995-11-09 1997-12-19 Adir Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE19600934A1 (de) 1996-01-12 1997-07-17 Basf Ag Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
WO1997028166A1 (de) 1996-02-01 1997-08-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Thienochinoline
AU1618697A (en) 1996-02-06 1997-08-28 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
JPH09291034A (ja) 1996-02-27 1997-11-11 Yoshitomi Pharmaceut Ind Ltd 縮合ピリジン化合物およびその医薬としての用途
US5710274A (en) 1996-02-28 1998-01-20 Neurogen Corporation N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
US5763609A (en) 1996-03-21 1998-06-09 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of gaba brain receptor ligands
US5703237A (en) 1996-04-18 1997-12-30 Neurogen Corporation N-Aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands
US5688950A (en) 1996-04-23 1997-11-18 Neurogen Corporation Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
NZ332477A (en) * 1996-05-11 2000-07-28 Smithkline Beecham Plc Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors
CA2263284A1 (en) * 1996-08-14 1998-02-19 Smithkline Beecham P.L.C. Tetrahydroisoquinoline derivatives and their pharmaceutical use
WO1998007421A1 (fr) 1996-08-16 1998-02-26 Ishihara Sangyo Kaisha, Ltd. Composition medicinale
WO1998023593A1 (en) 1996-11-27 1998-06-04 Pfizer Inc. Apo b-secretion/mtp inhibitory amides
FR2761985B1 (fr) 1997-04-10 1999-05-21 Adir Nouveaux composes amines du 6,7,8,9-tetrahydro-cyclopenta[a] naphtalene et du 2,3-dihydro-cyclopenta[e]indene, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO1998048784A2 (en) 1997-04-28 1998-11-05 The University Of British Columbia Method and composition for modulating amyloidosis
GB9708694D0 (en) 1997-04-30 1997-06-18 Smithkline Beecham Plc Compounds
WO1998050364A1 (en) * 1997-05-03 1998-11-12 Smithkline Beecham Plc Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
GB9709303D0 (en) 1997-05-09 1997-06-25 Smithkline Beecham Plc Compounds
GB9710612D0 (en) 1997-05-23 1997-07-16 Glaxo Group Ltd Synthesis of acridine derivatives
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
GB9812522D0 (en) 1998-06-10 1998-08-05 Smithkline Beecham Plc Compounds
GB9821977D0 (en) 1998-10-08 1998-12-02 Smithkline Beecham Plc Compounds
GB9821978D0 (en) 1998-10-08 1998-12-02 Smithkline Beecham Plc Compounds
DE69929704T2 (de) 1998-10-08 2006-07-20 Smithkline Beecham Plc, Brentford Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel)
AR022230A1 (es) 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion

Also Published As

Publication number Publication date
CO5031252A1 (es) 2001-04-27
GB9810876D0 (en) 1998-07-22
JP2002515489A (ja) 2002-05-28
WO1999059974A1 (en) 1999-11-25
US6414154B1 (en) 2002-07-02
AU4262799A (en) 1999-12-06
EP1086084A1 (en) 2001-03-28
CA2332316A1 (en) 1999-11-25

Similar Documents

Publication Publication Date Title
AR023681A1 (es) Derivados de tetrahidrobenzazepinas, composiciones farmaceuticas y el uso de los mismos para la manufactura de un medicamento.
AR007077A1 (es) Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento
AR013078A1 (es) Derivados de tetrahidroisoquinoleina, una sal de los mismos, procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de losmismos en la preparacion de un medicamento.
AR053232A1 (es) Derivados de piridina condensadas, composiciones farmaceuticas que los contienen y su empleo en la fabricacion de agentes terapeuticos antiinflamatorios y para el tratamiento de enfermedades relacionadas con el sistema inmunologico.
AR035369A1 (es) Derivados de tetrahidrobenzazepina composiciones farmaceuticas que los comprenden, el uso de dichos derivados en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
HUP0203548A2 (hu) Új spirooxindolszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
AR048567A1 (es) Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas.
AR008291A1 (es) Derivados de tetrahidroisoquinolina, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y su uso para la preparacionde un medicamento.
AR010396A1 (es) Compuestos de quinolina y de quinazolina utiles en terapia, formulacion farmaceutica que los contiene, su uso en la fabricacion de un medicamento,procedimiento para su produccion y compuestos utiles en dicho procedimiento
DE60318030D1 (de) Piperazine-substituierte aryl-benzodiazepinen und ihre verwendung als dopaminrezeptor-antagonisten zur behandlung von psychose
AR021354A1 (es) Procedimiento para la preparacion de un compuesto derivado de quinolina y un procedimiento para preparar una composicion farmaceutica
BR0114881A (pt) Derivados de benzoxazinona, sua preparação e uso
MX9307654A (es) Derivados de amina, proceso para su preparacion y composicion farmaceutica que los contiene.
AR027744A1 (es) Compuestos de eter difenilico utiles en terapia
ES2154605B1 (es) Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3
AR037928A1 (es) Compuesto de 2-oxopirrolidin 3- sulfonamida, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento
AR016036A1 (es) Derivados de tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica y el uso de los mismos para la fabricacion de unmedicamento
ATE233242T1 (de) Chinoline und chinazoline verbindungen und ihre therapeutische anwendung
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
DE69934514D1 (de) Chinolinderivate als nk-2 und nk-3 rezeptor-liganden
HUP0203332A2 (hu) Ciklotiokarbamát-származékok, progeszteron receptor modulátorokként való alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
BRPI0812816B8 (pt) compostos derivados de sulfonil-quinolina, ligantes com preferência para subtipo de receptor mglur1 e mglur5, processos para a preparação dos referidos compostos, formulação farmacêutica compreendedo os referidos compostos e uso dos mesmos
AR016594A1 (es) DERIVADOS DE 3,4,5,7-TETRAHIDRO-PIRROLO[3',4':4,5]TIENO[2,3-d]PIRIMIDINA 3-SUSTITUIDOS Y SU USO PARA LA PREPARACION DE COMPOSICIONES FARMACEUTICAS
AR052258A1 (es) Derivados de fenilpiperazinas con una afinidad combinada para receptores de dopamina - d2 y sitios de reabsorcion de serotonina, composiciones farmaceuticas que los contienen y su empleo como medicamentos para el tratamiento de enfermedades del sistema nervioso central.
AR027644A1 (es) Compuestos de piridacinil fenil hidrazona, composicion farmaceutica que lo comprende y metodo para el tratamiento de una falla del corazon congestiva quelo emplea

Legal Events

Date Code Title Description
FB Suspension of granting procedure